Jenburkt Pharmaceuticals Ltd.
| BSE: 524731 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE354A01013 |
| BSE 00:00 | 24 Jun | 483.80 |
9.80 (2.07%) |
OPEN
484.60 |
HIGH
496.10 |
LOW
477.95 |
| NSE 05:30 | 01 Jan | Jenburkt Pharmaceuticals Ltd |
| OPEN | 484.60 |
| PREVIOUS CLOSE | 474.00 |
| VOLUME | 79 |
| 52-Week high | 699.70 |
| 52-Week low | 452.00 |
| P/E | 9.96 |
| Mkt Cap.(Rs cr) | 222 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Jenburkt Pharmaceuticals Ltd. (JENBURKTPHARMA) - Announcements
-
Jenburkt Pharmaceuticals Ltd Closure of Trading Window
24/06/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
08/06/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Statement Of Related Party Transactions For The Half Year Ended 31St March 2022.
04/06/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
28/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
28/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Declaration Of Book Closure And Record Date
27/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Corporate Action-Board approves Dividend
27/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Audited Financial Results For The Financial Year Ended 31 March 2022
27/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th May 2022
27/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Intimation Of Change Of Corporate Office Address And Email Address Of The Registrar And Transfer Age
25/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
18/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Corporate Action-Board to consider Dividend
16/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Board Meeting Intimation for To Consider And Approve Audited Standalone Financial Results For The Qu
16/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
02/05/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
19/04/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Certificate U/R 40(10) Of SEBI (LODR) Regulations 2015 For The Financial Year Ended On 31.03.2022..
18/04/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Disclosure Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018.
11/04/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Compliance Certificate U/R 7(3) Of The SEBI-LODR For The Financial Year Ended On 31St March 2022.
08/04/2022 | bse |
Downlaod PDF -
Jenburkt Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
07/04/2022 | bse
-
Jenburkt Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07/04/2022 | bse |
Downlaod PDF
Quick Links for Jenburkt Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
